FDA inspection
Bostal Drug Delivery Co., Ltd.: FDA inspection ending May 11, 2018
FDA inspection 1055187 · No Action Indicated (NAI) · Guangzhou
Key facts
| Inspection ID | 1055187 |
|---|---|
| Firm | Bostal Drug Delivery Co., Ltd. |
| FEI number | 3003548131 |
| Address | Bldg C2 Kaiyuan Avenue 11, F-6 Guangzhou High-Tech Industrial Development Zones |
| City | Guangzhou |
| Fiscal year | 2018 |
| Inspection end date | May 11, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data